Pramipexole in treatment-resistant depression: a 16-week naturalistic study (Q28217267)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: October 2002)

edit

Language	Label	Description	Also known as
English	Pramipexole in treatment-resistant depression: a 16-week naturalistic study	scientific article (publication date: October 2002)

Statements

instance of

scholarly article

0 references

title

Pramipexole in treatment-resistant depression: a 16-week naturalistic study (English)

0 references

main subject

treatment-resistant depression

1 reference

based on heuristic

inferred from title

author

Marianna Abelli

object named as

Marianna Abelli

series ordinal

10

0 references

Stefano Pini

object named as

Stefano Pini

series ordinal

4

0 references

Liliana Dell'Osso

series ordinal

2

object named as

Liliana Dell'Osso

0 references

Patricia R Houck

series ordinal

6

object named as

Patricia R Houck

0 references

Paolo Cassano

series ordinal

3

object named as

Paolo Cassano

0 references

Paola Rucci

series ordinal

5

object named as

Paola Rucci

0 references

author name string

Lorenzo Lattanzi

series ordinal

1

0 references

Alfredo Gemignani

series ordinal

7

0 references

Giulia Battistini

series ordinal

8

0 references

Annalisa Bassi

series ordinal

9

0 references

Giovanni B Cassano

series ordinal

11

0 references

language of work or name

English

0 references

publication date

October 2002

0 references

published in

Bipolar Disorders

0 references

volume

4

0 references

issue

5

0 references

page(s)

307-14

0 references

cites work

Definition and epidemiology of treatment-resistant depression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Possible use of amantadine in depression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Antidepressant-associated hypomania in outpatient depression: A 203-case study in private practice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Pramipexole as adjunct to haloperidol in schizophrenia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

21 January 2018

Tricyclic nonresponders: phenomenology and treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The mesolimbic dopamine system as a target for rapid antidepressant action

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving depression severity assessment--I. Reliability, internal validity and sensitivity to change of three observer depression scales

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Bipolar depression and antidepressant-induced mania: a naturalistic study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2002.01171.X

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1034/J.1399-5618.2002.01171.X

0 references

PubMed publication ID

12479663

0 references

ResearchGate publication ID

10992492

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28217267&oldid=2105409190"